US2002037870A1PendingUtilityA1

Method of inhibiting cancer cell growth using a vector expressing pRb2/p130

52
Priority: Jun 2, 1997Filed: Oct 3, 2001Published: Mar 28, 2002
Est. expiryJun 2, 2017(expired)· nominal 20-yr term from priority
Inventors:Antonio Giordano
C07K 14/4736A61K 48/00A61P 35/00
52
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods of inhibiting growth of cancer cells and treating cancer in a patient by administration of a vector expressing pRb2/p130 are provided.

Claims

exact text as granted — not AI-modified
1 . A method of treating cancer in a patient comprising administering to the patient suffering from cancer a composition containing a vector encoding pRb2/p130 so that growth of cancer cells is inhibited wherein the vector is an adenoviral vector or a retroviral vector.  
     
     
         2 . The method of  claim 1 , wherein cancer includes human glioblastoma.  
     
     
         3 . The method of  claim 1 , wherein cancer includes melanoma.  
     
     
         4 . The method of  claim 1 , wherein cancer includes breast cancer.  
     
     
         5 . The method of  claim 1 , wherein cancer includes lung cancer.  
     
     
         6 . The method of  claim 1 , wherein cancer includes endometrial cancer.  
     
     
         7 . The method of  claim 1 , wherein cancer includes stomach carcinoma.  
     
     
         8 . The method of  claim 1 , wherein the vector is an adenoviral vector.  
     
     
         9 . The method of  claim 1 , wherein the vector is a retroviral vector.

Join the waitlist — get patent alerts

Track US2002037870A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.